Gables Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1K | Hold |
60
| – | – | ﹤0.01% | 364 |
|
|
2025
Q4 | $10.1K | Hold |
60
| – | – | ﹤0.01% | 356 |
|
|
2025
Q3 | $8.66K | Hold |
60
| – | – | ﹤0.01% | 370 |
|
|
2025
Q2 | $7.59K | Hold |
60
| – | – | ﹤0.01% | 373 |
|
|
2025
Q1 | $7.67K | Hold |
60
| – | – | ﹤0.01% | 371 |
|
|
2024
Q4 | $7.93K | Hold |
60
| – | – | ﹤0.01% | 370 |
|
|
2024
Q3 | $8.74K | Hold |
60
| – | – | ﹤0.01% | 373 |
|
|
2024
Q2 | $8.24K | Sell |
60
-90
| -60% | -$12K | ﹤0.01% | 336 |
|
|
2024
Q1 | $20.6K | Hold |
150
| – | – | 0.01% | 270 |
|
|
2023
Q4 | $20.4K | Hold |
150
| – | – | 0.01% | 259 |
|
|
2023
Q3 | $18.3K | Hold |
150
| – | – | 0.01% | 251 |
|
|
2023
Q2 | $19K | Hold |
150
| – | – | 0.01% | 255 |
|
|
2023
Q1 | $19.4K | Hold |
150
| – | – | 0.01% | 255 |
|
|
2022
Q4 | $19.7K | Hold |
150
| – | – | 0.01% | 246 |
|
|
2022
Q3 | $18K | Hold |
150
| – | – | 0.01% | 243 |
|
|
2022
Q2 | $18K | Hold |
150
| – | – | 0.01% | 259 |
|
|
2022
Q1 | $20K | Hold |
150
| – | – | 0.01% | 258 |
|
|
2021
Q4 | $23K | Hold |
150
| – | – | 0.01% | 252 |
|
|
2021
Q3 | $24K | Hold |
150
| – | – | 0.02% | 249 |
|
|
2021
Q2 | $25K | Hold |
150
| – | – | 0.02% | 247 |
|
|
2021
Q1 | $23K | Sell |
150
-6
| -4% | -$953 | 0.01% | 276 |
|
|
2020
Q4 | $24K | Hold |
156
| – | – | 0.01% | 258 |
|
|
2020
Q3 | $21K | Hold |
156
| – | – | 0.01% | 264 |
|
|
2020
Q2 | $21K | Hold |
156
| – | – | 0.01% | 248 |
|
|
2020
Q1 | $17K | Hold |
156
| – | – | 0.01% | 258 |
|
|
2019
Q4 | $19K | Hold |
156
| – | – | 0.01% | 255 |
|
|
2019
Q3 | $16K | Hold |
156
| – | – | 0.01% | 266 |
|
|
2019
Q2 | $17K | Hold |
156
| – | – | 0.01% | 250 |
|
|
2019
Q1 | $17K | Hold |
156
| – | – | 0.01% | 254 |
|
|
2018
Q4 | $15K | Hold |
156
| – | – | 0.01% | 252 |
|
|
2018
Q3 | $19K | Hold |
156
| – | – | 0.01% | 248 |
|
|
2018
Q2 | $17K | Buy |
+156
| New | +$16.7K | 0.01% | 255 |
|
Other funds holding IBB
CB